Pegfilgrastim primary prophylaxis vs. current practice neutropenia management in elderly breast cancer patients receiving chemotherapy.

Pegfilgrastim primary prophylaxis vs. current practice neutropenia management in elderly breast cancer patients receiving chemotherapy.

Item
http://www.wikidata.org/entity/Q37596004
Chemotherapy-associated treatment burden in breast cancer patients receiving lipegfilgrastim or pegfilgrastim: secondary efficacy data from a phase III study.Prophylaxis of chemotherapy-induced febrile neutropenia with granulocyte colony-stimulating factors: where are we now?The impact of the granulocyte colony-stimulating factor on chemotherapy dose intensity and cancer survival: a systematic review and meta-analysis of randomized controlled trialsReal-world impact of granulocyte-colony stimulating factor on febrile neutropeniaTherapeutic management of breast cancer in the elderly.Triple-negative breast cancer in the older population.Prevention of chemotherapy-induced neutropenia with pegfilgrastim: pharmacokinetics and patient outcomes.Pegfilgrastim for the prevention of chemotherapy-induced febrile neutropenia in patients with solid tumors.Toxicity profile differences of adjuvant docetaxel/cyclophosphamide (TC) between Asian and Caucasian breast cancer patients.Comparison of pegfilgrastim on day 2 vs. day 4 as primary prophylaxis of intense dose-dense chemotherapy in patients with node-positive primary breast cancer within the prospective, multi-center GAIN study: (GBG 33).Incidence of neutropenia, chemotherapy delivery, and use of colony-stimulating factor in patients with non-Hodgkin lymphoma of different age groups.Healthcare utilisation in patients with breast cancer or non-Hodgkin lymphoma who experienced febrile neutropenia in the Netherlands: a retrospective matched control study using the PHARMO database.A randomized, multi-center, open-label, phase III study of once-per-cycle DA-3031, a pegylated G-CSF, in comparison with daily filgrastim in patients receiving TAC chemotherapy for breast cancer.
P2860

Pegfilgrastim primary prophylaxis vs. current practice neutropenia management in elderly breast cancer patients receiving chemotherapy.

Item
http://www.wikidata.org/entity/Q37596004
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 11 September 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Pegfilgrastim primary prophyla ...... tients receiving chemotherapy.
@en
Pegfilgrastim primary prophyla ...... tients receiving chemotherapy.
@nl
type
label
Pegfilgrastim primary prophyla ...... tients receiving chemotherapy.
@en
Pegfilgrastim primary prophyla ...... tients receiving chemotherapy.
@nl
prefLabel
Pegfilgrastim primary prophyla ...... tients receiving chemotherapy.
@en
Pegfilgrastim primary prophyla ...... tients receiving chemotherapy.
@nl
P1433
P1476
P2093
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P921
P356
P1433
P1476
Pegfilgrastim primary prophyla ...... tients receiving chemotherapy.
@en
P2093
P304
P31
P356
10.1016/J.CRITREVONC.2009.06.004
P433
P478
P50
P577
P5875
P698
P921